HABA LaboratoriesInc Balance Sheet Health
Financial Health criteria checks 3/6
HABA LaboratoriesInc has a total shareholder equity of ¥9.7B and total debt of ¥2.6B, which brings its debt-to-equity ratio to 26.6%. Its total assets and total liabilities are ¥14.2B and ¥4.5B respectively.
Key information
26.6%
Debt to equity ratio
JP¥2.59b
Debt
Interest coverage ratio | n/a |
Cash | JP¥3.77b |
Equity | JP¥9.71b |
Total liabilities | JP¥4.49b |
Total assets | JP¥14.20b |
Recent financial health updates
Recent updates
What Type Of Returns Would HABA LaboratoriesInc's(TYO:4925) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Mar 09These 4 Measures Indicate That HABA LaboratoriesInc (TYO:4925) Is Using Debt Reasonably Well
Feb 19Should You Be Impressed By HABA LaboratoriesInc's (TYO:4925) Returns on Capital?
Feb 01Is HABA Laboratories,Inc. (TYO:4925) A Smart Choice For Dividend Investors?
Jan 13HABA Laboratories,Inc.'s (TYO:4925) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Dec 25What Kind Of Investors Own Most Of HABA Laboratories,Inc. (TYO:4925)?
Dec 07A Look At HABA LaboratoriesInc's (TYO:4925) Share Price Returns
Nov 19Financial Position Analysis
Short Term Liabilities: 4925's short term assets (¥9.2B) exceed its short term liabilities (¥3.3B).
Long Term Liabilities: 4925's short term assets (¥9.2B) exceed its long term liabilities (¥1.2B).
Debt to Equity History and Analysis
Debt Level: 4925 has more cash than its total debt.
Reducing Debt: 4925's debt to equity ratio has increased from 17.7% to 26.6% over the past 5 years.
Debt Coverage: 4925's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 4925's interest payments on its debt are well covered by EBIT.